Aerie Pharmaceuticals: Guidance Is Unachievable After Failed Drug Launches; 70%+ Downside [Seeking Alpha]
Aerie Pharmaceuticals, Inc. (AERI)
Last aerie pharmaceuticals, inc. earnings: 2/20 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.aeriepharma.com/investor-relations
Company Research
Source: Seeking Alpha
Aerie Pharmaceuticals: Guidance Is Unachievable After Failed Drug Launches; 70%+ Downside AERI sell side estimates are too high Both Rhopressa and Rocklatan are significantly underwhelming street expectations. Guidance is too high and will need to be cut. I’ll begin with an analysis this quarter’s sales of Rhopressa and Rocklatan using weekly prescription data from Bloomberg / Symphony Health. The dates do not perfectly line up with quarter ends, but the difference is minimal and the monthly data for June is not available yet. Between the weeks ended January 4, 2019 and March 29, 2019, Bloomberg reports that there were 90,930 total retail prescriptions for Rhopressa. Since the company reported $10,852,000 in revenue for the quarter, that implies a $119.34 of net revenue per retail prescription reported on Bloomberg. Note that the Bloomberg data is an estimate of only retail pharmacy sales. However, I think the data is good enough for our purposes and it’s reasonable to hold this multi
Show less
Read more
Impact Snapshot
Event Time:
AERI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AERI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AERI alerts
High impacting Aerie Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics